Sarah Stabenfeldt

Title: Innovations by Sarah Stabenfeldt in Traumatic Brain Injury Research

Introduction

Sarah Stabenfeldt is an accomplished inventor based in Tempe, AZ (US). She has made significant contributions to the field of traumatic brain injury research. Her innovative work focuses on the discovery of biomarkers that can aid in the diagnosis and treatment of such injuries.

Latest Patents

Sarah holds a patent for "Temporal traumatic brain injury biomarkers and methods of use thereof." This patent describes a unique pipeline for biomarker discovery that employs domain antibody phage display, next-generation sequencing analysis, and nanotechnology strategies to generate antibody mimetics. The patent also discloses temporal biomarkers of traumatic brain injury and their methods of use. In some embodiments, the temporal biomarkers are synthetic peptides comprising the HCDR3 sequences identified using the disclosed pipeline. Additionally, the synthetic peptides have less than 30 amino acid residues and comprise a biotin scaffold linked to the HCDR3 sequences. She has 1 patent to her name.

Career Highlights

Sarah is affiliated with Arizona State University, where she continues her research and development in the field of traumatic brain injury. Her work has the potential to significantly impact the medical community and improve patient outcomes.

Collaborations

Some of her notable coworkers include Briana Martinez and Chris Diehnelt, who contribute to her research efforts and innovations.

Conclusion

Sarah Stabenfeldt's work in the field of traumatic brain injury research exemplifies the importance of innovation in medical science. Her contributions through her patent and collaborations are paving the way for advancements in diagnosis and treatment.